SLC6A3 and Parkinson disease: From a neurobiological perspective, this is directly related to the loss of dopamine nerve terminals and dopamine transporter (DAT) expression in the striatum, which is associated with depressive symptoms in PD (Jacobs et al., 2020; Wang et al., 2025).